The PCRS Patient Reference Group is an advisory group responsible for providing independent advice and feedback to the executive committee and trustees on how well the Society is performing in relation to the following objectives:

On 9 March 2023, the National Asthma and COPD Audit Programme (NACAP) launched its 2018/20 clinical outcomes summary report.

In this PCRS Podcast Dr Steve Holmes (GP and PCRS Executive Committee Member) is joined by Dr Robina Coker (Consultant & Honorary Senior Lecturer in Respiratory Medicine at Hammersmith Hospital and Imperial College London, and Clinical Director of the NationaI Institute of Health Research (NI

The Association for Respiratory Technology & Physiology (ARTP) have now updated their advice on how to reduce the risk of spreading viral respiratory infections when performing aerosol-generating procedures (AEGs) such as spirometry in primary care settings.

The PCRS Executive is the main standing committee of PCRS. It leads on the development and implementation of the activities of the charity.  We are now able announce that following the call for applications, the executive committee election results are as follows:

In this article we explore what healthcare policy is, why it matters, how we as healthcare professionals can influence UK healthcare policy and why we should. Carol Stonham is our immediate past Executive Chair and leads the PCRS Policy Forum.

In early 2022, trained respiratory healthcare practitioner nurses in general practice were invited to participate in the South West Primary Care Respiratory Champions Project funded by the South West Respiratory Network.

Given the direct impact of COVID-19 on those with existing breathing difficulties, the ‘newly breathless’ – those whose lung function has been impaired by Covid – as well as rising levels of air pollution, the need for social prescribing solutions in respiratory healthcare has never been greater.

The transformation of out of hospital services has been identified as a key element of the NHS recovery plan. Patient care delivered closer to or in their own homes was identified as a priority in the NHS Long Term Plan.

Non-tuberculous mycobacteria (NTM) are a group of bacteria that are capable of causing opportunistic lung infections and the development of NTM pulmonary disease (NTM-PD).

In this article we review the major changes in the 2023 GOLD report as they impact on the initial and ongoing pharmacological management of COPD and consider the implications for primary care in the UK.

This pragmatic guide on the identification, referral and ongoing management of adults and children with severe asthma has been developed by an expert group led by Dr Steve Holmes, a GP based in Shepton Mallet, Somerset and including Will Carroll, University Hospital of the North Midlands, Stoke-o